49.16
-0.49 (-0.99%)
Market Trend
| Short Term | Medium Term | ||
| Industry | Medical Devices (US) | Mixed | Bearish |
| Medical Devices (Global) | Mixed | Bearish | |
| Stock | Inari Medical, Inc. | Bullish | Bearish |
Stockmoo Score
|
Inari Medical Inc is a medical device company focused on developing products to treat patients suffering from Chronic Venous Disease. Its product portfolio includes; ClotTriever, for the removal of the clot from peripheral blood vessels and treats patients suffering from deep vein thrombosis. The FlowTriever System product is used for the treatment of pulmonary embolism, InThrill system to treat small vessel thrombosis, LimFlow system and others. Geographically, the company generates majority of its revenue from United States and rest from International markets. |
|
| Sector | Healthcare |
| Industry | Medical Devices |
| Investment Style | Small Growth |
| 52 Weeks Range | ||
| Price Target Range | ||
| High | 71.00 (Canaccord Genuity, 44.43%) | Buy |
| Median | 59.00 (20.02%) | |
| Low | 47.00 (Leerink Partners, -4.39%) | Hold |
| Average | 58.63 (19.26%) | |
| Total | 4 Buy, 4 Hold | |
| Avg. Price @ Call | 45.96 | |
| Firm | Date | Target Price | Call | Price @ Call |
|---|---|---|---|---|
| Stifel | 17 Sep 2024 | 50.00 (1.71%) | Hold | 46.00 |
| Leerink Partners | 03 Sep 2024 | 47.00 (-4.39%) | Hold | 43.74 |
| Piper Sandler | 26 Aug 2024 | 50.00 (1.71%) | Hold | 43.04 |
| Deutsche Bank | 09 Aug 2024 | 68.00 (38.32%) | Buy | 48.65 |
| Baird | 31 Jul 2024 | 63.00 (28.15%) | Buy | 46.56 |
| Canaccord Genuity | 31 Jul 2024 | 71.00 (44.43%) | Buy | 46.56 |
| Truist Securities | 31 Jul 2024 | 55.00 (11.88%) | Hold | 46.56 |
| 16 Jul 2024 | 60.00 (22.05%) | Hold | 57.98 | |
| Wells Fargo | 31 Jul 2024 | 65.00 (32.22%) | Buy | 46.56 |
No data within this time range.
| Date | Type | Details |
|---|---|---|
| 29 Aug 2024 | Announcement | Inari Medical Announces PEERLESS Data to be Presented During the Late-Breaking Clinical Trial Sessions at TCT 2024 |
| 21 Aug 2024 | Announcement | Inari Medical to Present at Upcoming Investor Conferences |
| 30 Jul 2024 | Announcement | Inari Medical Announces Chief Financial Officer Retirement and Succession Plan |
| 30 Jul 2024 | Announcement | Inari Medical Reports Second Quarter 2024 Financial Results |
| 16 Jul 2024 | Announcement | Inari Medical to Announce Second Quarter 2024 Financial Results |
| 18 Jun 2024 | Announcement | Kaplan Fox Files Class Action to Recover Losses for Investors Who Purchased Common Stock of Inari Medical, Inc. (NasdaqGS: NARI) for an Expanded Class Period March 10, 2021 through February 28, 2024 |
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2024 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |